-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Compass Therapeutics Doses First Patient in Phase 2 Trial of CTX-009 to Treat Colorectal Cancer; Shares Rise

Compass Therapeutics Doses First Patient in Phase 2 Trial of CTX-009 to Treat Colorectal Cancer; Shares Rise

MT Newswires · 01/06/2023 06:44